Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18459150 | 0.97 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3DAOLMNA | |
| SCHEMBL17548020 | 0.96 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3DAOLMNA | |
| SCHEMBL18503377 | 0.88 | HRH3 (0.40) | SLC6A2SLC6A4SLC6A3LMNAMAOB | |
| SCHEMBL9979951 | 0.87 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL8153283 | 0.87 | SLC6A2 (0.42) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL19887761 | 0.84 | LMNA (0.38) | SLC6A2SLC6A4SLC6A3DAOLMNA | |
| SCHEMBL11933091 | 0.84 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL17548064 | 0.84 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3DAOCHRM5 | |
| SCHEMBL13433711 | 0.83 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3DAOMAOB | |
| SCHEMBL13791065 | 0.83 | PROKR1 (0.37) | SLC6A2SLC6A4SLC6A3DRD4MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043782-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| US-20230053362-A1 | DICHROIC DYE COMPOSITION | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-11312908-B2 | Liquid crystal medium and liquid crystal display | MERCK PATENT GMBH (DE) | 2022-04-26 | — | — | US | disclosed |
| US-11168257-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2021-11-09 | — | — | US | disclosed |
| US-20210238481-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (JP) | 2021-08-05 | — | — | US | disclosed |
| US-10982150-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2021-04-20 | — | — | US | disclosed |
| WO-2021042281-A1 | LIQUID CRYSTAL COMPOSITION AND USE THEREOF | 北京八亿时空液晶科技股份有限公司 | 2021-03-11 | — | — | WO | disclosed |
| US-20190241811-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-08-08 | — | — | US | disclosed |
| US-20190153320-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-05-23 | — | — | US | disclosed |
| US-20180195002-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2018-07-12 | — | — | US | disclosed |
| US-20180163134-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2018-06-14 | — | — | US | disclosed |
| US-20170029698-A1 | ANTIOXIDANT FOR LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE USING LIQUID CRYSTAL COMPOSITION | DIC CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
| US-9487704-B2 | Nematic liquid crystal composition and liquid crystal display element using same | DIC CORPORATION (JP) | 2016-11-08 | — | — | US | disclosed |
| US-20160319195-A1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME | DIC CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
| US-20160060526-A1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238481-A1 | LIQUID CRYSTALLINE MEDIUM | NEFM, CCNI, MYT1 | SLC6A2 2163/4885SLC6A4 1250/4885SLC6A3 1582/4885 |
| US-11667845-B2 | Liquid crystalline medium | NEFM, CCNI, MYT1 | SLC6A2 2163/4885SLC6A4 1250/4885SLC6A3 1582/4885 |
| US-20170029698-A1 | ANTIOXIDANT FOR LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE USING LIQUID CRYSTAL COMPOSITION | GPX1, LPO, SCO2 | SLC6A2 2770/4885SLC6A4 4137/4885SLC6A3 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.